Nutritional Management of Liver Cirrhosis

Guideline-Based Recommendations

The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends a protein intake of 1.2-1.5 g/kg body weight/day using whole protein formulas for cirrhotic patients 1, 2, 3
The American Association for the Study of Liver Diseases (AASLD) suggests an energy intake of 35-40 kcal/kg body weight/day for cirrhotic patients 1, 2, 3
Standard enteral formulas are recommended as first-line nutritional support by ESPEN guidelines 3, 4, 5
The ESPEN guidelines explicitly state that standard enteral formulas can be given, as there are no data regarding the value of disease-specific compositions including keto acid formulations 4, 6

BCAA-enriched formulas should be used specifically in patients with hepatic encephalopathy arising during enteral nutrition, as recommended by the Clinical Nutrition journal 1, 2, 3
Long-term BCAA supplementation (12-24 months) may improve surrogate markers and quality of life in advanced cirrhosis, according to the Clinical Nutrition journal 3
The American Association for the Study of Liver Diseases (AASLD) does NOT recommend long-term BCAA supplementation beyond recommended protein intake targets from diverse protein sources 7

The Subjective Global Assessment (SGA) or anthropometry should be used to identify malnutrition risk, with a target protein intake of 1.2-1.5 g/kg/day and energy intake of 35-40 kcal/kg/day 1, 2, 3
Oral nutrition and oral nutritional supplements (ONS) should be started when oral intake is inadequate, as recommended by the Clinical Nutrition journal 1, 2
Tube feeding (nasogastric/nasojejunal) should be used if oral intake cannot meet targets, even with esophageal varices present, according to the Clinical Nutrition journal 1, 2, 3
Parenteral nutrition should be used only as second-line when oral/enteral routes are ineffective or not feasible, as suggested by the Clinical Nutrition journal 5

Standard whole protein formulas should be used as first-line, as recommended by the Clinical Nutrition journal 1, 2, 3, 4, 5
BCAA-enriched formulas should be used ONLY if hepatic encephalopathy develops during enteral nutrition, according to the Clinical Nutrition journal 1, 2, 3

Protein intake should not be restricted in hepatic encephalopathy, as this outdated practice worsens malnutrition without proven benefit, according to the Hepatology journal 7
Specialized "hepatic formula" amino acid solutions should not be used routinely, as meta-analyses show contradictory results, according to the Clinical Nutrition journal 5
PEG tubes should not be used in cirrhotic patients, as PEG placement carries higher complication risks due to ascites and varices, according to the Clinical Nutrition journal 1, 2, 3